Santhera Pharmaceuticals announces the appointment of Orlando Oliveira as Chief Executive Officer (CEO), effective July 15, 2026. He succeeds Dario Eklund, who will step...
Santhera Pharmaceuticals and ReveraGen BioPharma, Inc announce that the first patient has been dosed in a Phase 2 pilot study to assess vamorolone in...